About Generic Aadhaar
Generic Aadhaar is a Healthcare company based in Thane (India) founded in 2018 by Arjun Deshpande. Manufacturer of generic drugs. Generic Aadhaar has raised $1.97 million across 2 funding rounds from investors including Beyond Next Ventures and Ratan N Tata. Generic Aadhaar was last valued at $15.69 million in May 2022. Its chief executive, as recorded, is Arjun Deshpande. Its website genericaadhaar.com draws about 63 thousand monthly visits. Its Indian entity Swasthya Lifescience Private Limited reported revenue of βΉ24.57 Cr. Generic Aadhaar offers products and services including Generic Medicines and Pharmacy Franchises. Its focus areas include Pharmacies and Pharmaceutical Drugs.
Company details
Generic Aadhaar was founded in 2018 in Thane, India, within the pharmaceuticals sector. Operations focus on producing and distributing generic drugs, with direct sales to end-users facilitated through a mobile application for home delivery. Franchise opportunities for standalone pharmacies are supported to enable competition with larger retail chains and online platforms across India.
- Headquarters Thane, India
- Founders Arjun Deshpande
- Stage Minicorn
- SectorsHealthcare
- Website category Finance · Investing
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website genericaadhaar.com
- Social LinkedIn Facebook Instagram
- Legal Name Swasthya Lifescience Private Limited
- Date of Incorporation 24 Feb, 2020
- Jurisdiction Kalwa, Maharashtra, India
- Annual Revenue₹24.57 Cr
FY 2025 · +26% YoY
- Net Profit₹1.49 Cr
FY 2025 · 6% margin
- EBITDA₹2.15 Cr
FY 2025 · 9% margin
- Total Equity Funding$1.97M (USD)
in 2 rounds
- Latest Funding Round$1.96M (USD), Seed
May 2022
- InvestorsBeyond Next Ventures
& 1 more
Associated legal entities of Generic Aadhaar
Generic Aadhaar operates through Swasthya Lifescience Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Swasthya Lifescience Private Limited CIN U51909MH2020PTC338175 | Active | 24 Feb 2020 | Kalwa, Maharashtra | ₹24.6 Cr | 2 | View details |
Products & Services of Generic Aadhaar
Generic Aadhaar offers a comprehensive portfolio of products and services, including Generic Medicines and Pharmacy Franchises.
Affordable generic drugs are supplied for daily use, addressing high medicine prices in the market.
Franchise opportunities are offered to empower medical store owners and entrepreneurs with branding and support.
Funding Insights of Generic Aadhaar
Generic Aadhaar has successfully raised a total of $1.97M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.96 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.97M
- Total Rounds 2
- Last Round Seed β $1.96M
- First Round $13,280
(May 2020)
- Investors Count 2
All 2 funding rounds of Generic Aadhaar with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2022 | $1.96M | Seed | $15.69M | Beyond Next Ventures | β |
| May 2020 | $13,280 | Angel Round | $195,578 | Ratan N Tata | β |
| Date | Valuation | Stage |
|---|---|---|
| May 2022 | $15.69M | β’β’β’β’β’β’β’β’ |
Last known valuation $15.69M (May 2022). 2 investors in total: 1 institutional and 1 angel.
Investors in Generic Aadhaar
Generic Aadhaar has secured backing from 2 investors, including venture fund and angel investors. Prominent investors backing the company include Beyond Next Ventures and Ratan N Tata.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Deep-tech investments and incubation services are provided for researchers and entrepreneurs addressing global challenges. | 2014 | beyondnextventures.com | Tokyo, Japan | |
RN Ratan N Tata | Chairman Emeritus of Tata Sons, iconic industrialist, and active angel investor | unknown_e1a9d6c95ff94f5f9 |
Investor details for Generic Aadhaar
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Swasthya Lifescience Private Limited (Generic Aadhaar)
Swasthya Lifescience Private Limited is the primary company behind Generic Aadhaar. The board of Swasthya Lifescience Private Limited currently have 2 directors; the longest-serving is Aarti Rajesh Deshpande, appointed in 2020. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Aarti Rajesh Deshpande DIN 07737832 | Director | 06 May 2020 | 6 yrs 6 mo | Swasthya Lifescience Private Limited |
| Arjun Rajesh Deshpande DIN 08746367 | Director | 23 May 2020 | 6 yrs 5 mo | Swasthya Lifescience Private Limited |
People of Generic Aadhaar
1 people are tracked at Generic Aadhaar (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership |
Complete people profiles for Generic Aadhaar
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Generic Aadhaar
Figures of Swasthya Lifescience Private Limited, the primary company behind Generic Aadhaar, for FY 2025. Revenue was ₹24.57 Cr (+26% year on year). Net profit was ₹1.49 Cr (6% margin). EBITDA was ₹2.15 Cr (9% margin). Revenue has grown at a compounded annual rate of +41% over three years and +504% over five years.
- ₹24.57 CrRevenue · FY 2025 · +26% YoY
- ₹1.49 CrNet profit · 6% margin
- ₹2.15 CrEBITDA · 9% margin
- ₹1.2 LakhPaid-up capital
- +41%Revenue CAGR, 3 years
- +504%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Swasthya Lifescience Private Limited are on its company page.
Detailed financial statements for Generic Aadhaar
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Generic Aadhaar
4 dated milestones of Generic Aadhaar across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Generic Aadhaar is founded.
- Funding First funding round of $13K.
- Funding Latest funding round, Seed, of $2.0M.
- Milestone Reaches Minicorn status.
Web traffic of Generic Aadhaar
The website of Generic Aadhaar (genericaadhaar.com) receives about 62.7K visits a month and ranks #325,230 among all websites worldwide, #3,421 in Investing.
- Monthly visits62.7K
▼ 23.6% vs previous month
- Unique visitors25.4K
per month
- Global rank#325,230
among all websites
- Category rank#3,421
Finance · Investing
- Bounce rate52%
- Pages per visit6.3
- Average visit3 min 02 sec
- DevicesDesktop 9% Β· Mobile 91%
Websites whose visitors overlap most with Generic Aadhaar. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| wellnessforever.com | 100% | 480.8K | #74,529 | View details | |
| davaindia.com | 82% | 121K | #262,189 | View details | |
| medibuddy.in | 60% | 1.4M | #38,660 | View details | |
| universalsompo.com | 60% | 227.5K | #202,321 | View details | |
| vvcmc.in | 60% | #306,120 | View details | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 10 similar websites and full traffic analytics for Generic Aadhaar
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Generic Aadhaar
Generic Aadhaar was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Generic Aadhaar is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.
Arjun Deshpande is the CEO of Generic Aadhaar, as recorded in our data. They have also founded this company.
Generic Aadhaar is a funded company, having raised a total of $1.97M across 2 funding rounds to date. The company's 1st funding round was a Angel Round of $13.28K, raised on May 2020.
The primary company behind Generic Aadhaar, Swasthya Lifescience Private Limited, reported revenue of βΉ24.57 Cr for FY 2025, up 26% year on year.
Generic Aadhaar was founded in 2018 in Thane, India, within the pharmaceuticals sector. Operations focus on producing and distributing generic drugs, with direct sales to end-users facilitated through a mobile application for home delivery. Franchise opportunities for standalone pharmacies are supported to enable competition with larger retail chains and online platforms across India.
Generic Aadhaar offers Generic Medicines and Pharmacy Franchises.
Generic Aadhaar has 2 investors. Key investors include Beyond Next Ventures, and Ratan N Tata.
The valuation of Generic Aadhaar is $15.69M as of May 2022.
Generic Aadhaar operates through Swasthya Lifescience Private Limited.
The legal entities of Generic Aadhaar currently have 2 directors, including Arjun Rajesh Deshpande, Aarti Rajesh Deshpande.
